The global immune checkpoint inhibitors (ICI) market is set for significant expansion, projected to grow from USD 62.51 billion in 2024 to USD 189.40 billion by 2033, registering a robust CAGR of 11.98% during the forecast period (2025–2033). The surge in cancer prevalence, increasing adoption of immunotherapy, and rapid advancements in precision medicine are key...
0 Commentarios
0 Acciones
514 Views
0 Vista previa
English
Arabic
French
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek